@article{JTD25112,
author = {Derek Nichols and Theresa A. Boyle and David Noyes and Kujtim Latifi and Vladimir Feygelman and Isabel Jackson and Zeljko Vujaskovic and Scott Antonia and Bradford A. Perez},
title = {Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {11},
year = {2018},
keywords = {},
abstract = {Outcomes for patients with inoperable locally advanced non-small cell lung cancer (LA-NSCLC) are poor, with a median survival of about 2 years (1) and a 5-year survival of about 10–15% following diagnosis, even among patients with good performance status at presentation (2). Despite these poor outcomes, conventional radiation therapy (RT) with chemotherapy remains the standard of care.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/25112}
}